Table 5.
Projected incremental costs and effects in 2030 with family planning at 70%
| Additional lives saved | Incremental costs (US$) | Life years gained | Incremental cost (US$)/LY gained | |||
|---|---|---|---|---|---|---|
| Stillbirth | Maternal | Neonatal | ||||
| Interventions for stillbirth prevention | ||||||
| Syphilis detection and treatment | 160 | - | 0 | 106 550 | 9 600 | 11 |
| Hypertensive disease case management | 460 | 150 | - | 35 040 | 31 650 | 1 |
| Diabetes case management | 180 | - | - | 8 194 520 | 10 800 | 759 |
| MgSO4 Management of pre-eclampsia | 450 | 70 | - | 5 492 600 | 28 890 | 190 |
| Fetal growth restriction detection and management | 690 | - | - | 2 876 410 | 41 400 | 69 |
| Labor and delivery management | 3 050 | 400 | 1 540 | 19 447 320 | 286 200 | 68 |
| Induction of labor for pregnancies lasting 41+ weeks | 390 | - | - | 2 436 610 | 23 400 | 104 |
| Interventions for maternal and newborn health | ||||||
| Early detection and treatment of HIV | - | 610 | - | 10 930 280 | 16 470 | 664 |
| Tetanus toxoid immunization | - | 2 | 50 | 614 240 | 3 054 | 201 |
| Antibiotics for PPROM | - | 20 | 470 | 769 780 | 28 740 | 27 |
| Antenatal corticosteroids | - | - | 2 030 | 4 527 270 | 121 800 | 37 |
| Active management of the third stage of labor | - | 80 | - | 1 547 670 | 2 160 | 717 |
| Neonatal resuscitation | - | - | 760 | 81 670 | 45 600 | 2 |
| Total | 5 380 | 1 332 | 4 850 | 57 059 960 | 649 764 | 88 |
US$ = United States Dollars; numbers rounded to nearest 10 to indicate uncertainty.